SWP
ARKG icon

Stratos Wealth Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Stratos Wealth Partners’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,058
Closed -$204K – 1626
2025
Q4 		$204K Buy
+7,058
New +$212K ﹤0.01% 1507
2024
Q4 		– Sell
-8,859
Closed -$227K – 1458
2024
Q3 		$227K Sell
8,859
-1,442
-14% -$36.7K ﹤0.01% 1278
2024
Q2 		$242K Sell
10,301
-2,051
-17% -$51.8K ﹤0.01% 1183
2024
Q1 		$355K Sell
12,352
-1,745
-12% -$52.5K 0.01% 1025
2023
Q4 		$463K Sell
14,097
-1,531
-10% -$41.6K 0.01% 897
2023
Q3 		$435K Buy
15,628
+7,528
+93% +$246K 0.01% 871
2023
Q2 		$276K Sell
8,100
-1,027
-11% -$32.3K 0.01% 993
2023
Q1 		$274K Sell
9,127
-1,375
-13% -$42.6K 0.01% 904
2022
Q4 		$296K Sell
10,502
-282
-3% -$8.95K 0.01% 896
2022
Q3 		$354K Sell
10,784
-4,298
-28% -$158K 0.01% 802
2022
Q2 		$475K Sell
15,082
-6,452
-30% -$226K 0.01% 748
2022
Q1 		$989K Sell
21,534
-15,713
-42% -$749K 0.02% 557
2021
Q4 		$2.28M Sell
37,247
-13,512
-27% -$934K 0.05% 321
2021
Q3 		$3.79M Sell
50,759
-22,256
-30% -$1.87M 0.1% 211
2021
Q2 		$6.75M Sell
73,015
-10,684
-13% -$908K 0.17% 129
2021
Q1 		$7.43M Buy
83,699
+22,285
+36% +$2.21M 0.21% 107
2020
Q4 		$5.73M Buy
61,414
+28,531
+87% +$2.27M 0.17% 134
2020
Q3 		$2.1M Buy
32,883
+21,966
+201% +$1.29M 0.07% 255
2020
Q2 		$569K Buy
+10,917
New +$468K 0.02% 551
2018
Q4 		– Sell
-140
Closed -$5K – 938
2018
Q3 		$5K Buy
+140
New +$4.43K ﹤0.01% 2426
2018
Q2 		– Sell
-140
Closed -$4K – 1060
2018
Q1 		$4K Buy
+140
New +$3.79K ﹤0.01% 2656

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Stratos Wealth Partners's ARKG Position: Q1 2026 in Review

Stratos Wealth Partners sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 7,058 shares — an estimated $204K sold.

Stratos Wealth Partners first reported a position in ARKG in Q1 2018 and held it in 21 quarters. The position peaked at $7.43M in Q1 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Stratos Wealth Partners reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
  • Stratos Wealth Partners sold 7,058 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $204K.
  • Stratos Wealth Partners first reported a position in ARK Genomic Revolution ETF in Q1 2018 and held it in 21 quarters.
  • Stratos Wealth Partners's ARK Genomic Revolution ETF position peaked at $7.43M in Q1 2021.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.